ArticleEClinicalMedicine2021
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial.
Sam Amin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it